| 1 |
Diercks DB, Owen KP, Kline JA, et al. Urine meta-bolomic analysis to detect metabolites associated with the development of contrast induced nephropathy[J]. Clin Exp Emerg Med, 2016, 3 (4): 204-212.
|
| 2 |
Wang L, Ni Z, Xie Z, et al. Analysis of the urine p-roteome of human contrast-induced kidney injury using two-dimensional fluorescence differential gel electrophoresis /matrix-assisted laser desorption time-of-flight mass spectrometry / liquid chromatography mass spectrometry[J]. Am J Nephrol, 2010, 31 (1): 45-52.
|
| 3 |
韩利娜，周芳芳，罗群. 尿液蛋白质组学在不同病因急性肾损伤早期诊断中的应用[J]. 中华肾脏病杂志，2016，32(4):314-316.
|
| 4 |
Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med, 2013, 158 (11): 825-830.
|
| 5 |
Sigdel TK, Salomonis N, Nicora CD, et al. The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics[J]. Mol Cell Proteomics, 2014, 13 (2): 621-631.
|
| 6 |
Chen C, Yang X, Lei Y, et al. Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome[J]. Clin J Am Soc Nephrol, 2016, 11 (9): 1536-1544.
|
| 7 |
Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption[J]. Clin Chem Lab Med, 2017, 55 (8): 1074-1089.
|
| 8 |
Nakano D, Kobori H, Burford JL, et al. Multiphoton im-aging of the glomerular permeability of angiotensinogen[J]. J Am Soc Nephrol, 2012, 23 (11): 1847-1856.
|
| 9 |
Yang X, Chen C, Tian J, et al. Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: a prospective, two-stage study[J]. J Am Soc Nephrol, 2015, 26 (8): 2032-2041.
|
| 10 |
Alge JL, Karakala N, Neely BA, et al. Urinary angiotensinogen and risk of severe AKI[J]. Clin J Am Soc Nephrol, 2013, 8 (2): 184-193.
|
| 11 |
Alge JL, Karakala N, Neely BA, et al. Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit[J]. Crit Care, 2013, 17 (2): R69.
|
| 12 |
郭冬华，徐延琴. 尿血管紧张素原的临床意义[J]. 中国中西医结合肾病杂志，2016，17(2):187-188.
|
| 13 |
Zhang J, Rudemiller NP, Patel MB, et al. Competing actions of type 1 angiotensin Ⅱ receptors expressed on T lymphocytes and kidney epithelium during cisplatin-induced AKI[J]. J Am Soc Nephrol, 2016, 27 (8): 2257-2264.
|
| 14 |
Yongqing T, Drentin N, Duncan RC, et al. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?[J]. Biochim Biophys Acta, 2012, 1824 (1): 253-262.
|
| 15 |
王玲，倪兆慧，谢振声，等. 荧光差异电泳和质谱技术联合研究对比剂肾损伤尿液差异表达蛋白[J]. 中华医学杂志，2011，91(32):2250-2253.
|
| 16 |
Osthoff M, Trendelenburg M. Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction[J]. Biomed Res Int, 2013: 962695.
|
| 17 |
Schwaeble WJ, Lynch NJ, Clark JE, et al. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia /reperfusion injury[J]. Proc Natl Acad Sci U S A, 2011, 108 (18): 7523-7528.
|
| 18 |
Roveran Genga K, Lo C, Cirstea M, et al. Two-year follow-up of patients with septic shock presenting with low HDL: the effect upon acute kidney injury, death and estimated glomerular filtration rate[J]. J Intern Med, 2017, 281 (5): 518-529.
|
| 19 |
Lu Z, Cheng D, Yin J, et al. Antithrombin Ⅲ protects against contrast-induced nephropathy[J]. EBioMedicine, 2017 (17): 101-107.
|
| 20 |
Wang F, Zhang G, Lu Z, et al. Antithrombin Ⅲ / SerpinC1 insufficiency exacerbates renal ischemia / reperfusion injury[J]. Kidney Int, 2015, 88 (4): 796-803.
|